These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20217203)

  • 21. Protective role of chronic statin therapy in reducing myocardial damage during percutaneous coronary intervention.
    Auguadro C; Manfredi M; Scalise F; Mortara A; Specchia G
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):416-21. PubMed ID: 16721204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study).
    Veselka J; Hájek P; Tomašov P; Tesař D; Brůhová H; Matějovič M; Branny M; Studenčan M; Zemánek D
    Am J Cardiol; 2014 Feb; 113(3):446-51. PubMed ID: 24304551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Ann Clin Biochem; 2002 Jul; 39(Pt 4):392-7. PubMed ID: 12117443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.
    Briguori C; Madonna R; Zimarino M; Calabrò P; Quintavalle C; Salomone M; Condorelli G; De Caterina R
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):465-472. PubMed ID: 27358173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
    Toso A; Leoncini M; Maioli M; Gallopin M; Tedeschi D; Amato M; Bellandi F
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):318-21. PubMed ID: 21045713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.
    Briguori C; Visconti G; Focaccio A; Golia B; Chieffo A; Castelli A; Mussardo M; Montorfano M; Ricciardelli B; Colombo A
    J Am Coll Cardiol; 2009 Dec; 54(23):2157-63. PubMed ID: 19664895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of rosuvastatin to prevent periprocedural myocardial injury in patients undergoing elective coronary intervention.
    Takano H; Ohba T; Yamamoto E; Miyachi H; Inui K; Kawanaka H; Kamiya M; Kikuchi A; Takahashi Y; Tanabe J; Inami S; Takagi G; Asai K; Yasutake M; Ibuki C; Tanaka K; Kusama Y; Seino Y; Munakata K; Mizuno K;
    Am J Cardiol; 2013 Jun; 111(12):1688-93. PubMed ID: 23507709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Sun F; Yin Z; Shi Q; Zhao B; Wang S
    Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
    Zemánek D; Branny M; Martinkovičová L; Hájek P; Malý M; Tesař D; Tomašov P; Veselka J
    Int J Cardiol; 2013 Oct; 168(3):2494-7. PubMed ID: 23597577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
    Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
    Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention].
    Lin ZP; Shu PC; Liao ZJ; Wang XQ; Liu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1789-91. PubMed ID: 22027793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
    Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
    JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peri-operative myocardial injury in patients undergoing surgery for critical limb ischaemia.
    Hobbs SD; Yapanis M; Burns PJ; Wilmink AB; Bradbury AW; Adam DJ
    Eur J Vasc Endovasc Surg; 2005 Mar; 29(3):301-4. PubMed ID: 15694805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention.
    Bonello L; Sbragia P; Amabile N; Com O; Pierre SV; Levy S; Paganelli F
    Heart; 2007 Jun; 93(6):703-7. PubMed ID: 17488771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
    Foroughinia F; Salamzadeh J; Namazi MH
    Cardiovasc Ther; 2013 Oct; 31(5):268-73. PubMed ID: 23134549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Increase in troponin levels after coronary angioplasty (PTCA) in stable angina pectoris].
    Varvarovský I; Brtko M; Branny M
    Vnitr Lek; 2004 Mar; 50(3):203-7. PubMed ID: 15125370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.